‘We’re Creating A Global Presence’ – Aspargo Labs CEO On Reformulating Drugs And Smart Devices
Aspargo Labs Wants To Create A New Area Of Patient Support That Has Not Yet Existed
In an exclusive interview with Generics Bulletin, Aspargo Labs CEO Michael Demurjian discusses the importance of reformulated liquid oral suspension drugs, while outlining plans to launch a smart device that connects patients and doctors.
